TrialsgrambetaRCTs are beautiful

ICAP

2013

Investigation on Colchicine for Acute Pericarditis

In 240 patients with a first episode of acute pericarditis, colchicine added to conventional anti-inflammatory therapy reduced incessant or recurrent pericarditis compared with placebo.

Result

Incessant or recurrent pericarditis
Absolute difference
20.8 points
NNT
5
Effect estimate

relative risk reduction0.5695% CI 0.30-0.72 · P < 0.001

Absolute difference and NNT are derived from the event rates.

Also reported: Remission at 1 week 85.0 % vs 58.3 %. Adverse events comparable.

Original publication
Subtopic
Acute pericarditis
Design
Double-blind, placebo-controlled RCT
Relevance
Practice-defining: a trial the guidelines cite as evidence.
Source
Imazio M, Brucato A, Cemin R, et al. N Engl J Med. 2013;369(16):1522-1528.doi 10.1056/NEJMoa1208536

Discussion & critique

Modest in size, Italian centres only, and bacterial and neoplastic aetiologies were excluded, so the effect applies to idiopathic or viral pericarditis. It converted colchicine from a rescue drug into routine first-line adjunctive therapy from the first attack onwards.

Discussed in podcasts